Mobia Medical prices $150M initial public offering and begins trading on Nasdaq under the ticker MOBI by thaan@22fillmore.com | May 7, 2026 | Portfolio News
Veradermics announces positive Phase 3 Study 302 topline results for VDPHL01 in male pattern hair loss by mariel | Apr 27, 2026 | Portfolio News
Mirum Pharmaceuticals announces primary endpoint met in Phase 2b portion of the AZURE-1 Study of brelovitug in chronic hepatitis delta virus by mariel | Apr 27, 2026 | Portfolio News
BioAge Labs reports positive Phase 1 data for oral NLRP3 inhibitor BGE-102 in people with obesity and elevated inflammation by thaan@22fillmore.com | Apr 21, 2026 | Portfolio News
Opna Bio receives FDA Fast Track designation for OPN-6602 in relapsed or refractory multiple myeloma by thaan@22fillmore.com | Apr 15, 2026 | Portfolio News
Viridian Therapeutics reports positive Phase 3 REVEAL-1 results for elegrobart in active thyroid eye disease by mariel | Mar 30, 2026 | Portfolio News
